Northwestern Mutual Wealth Management Co. Has $8.10 Million Stock Position in Sanofi $SNY

Northwestern Mutual Wealth Management Co. lifted its stake in Sanofi (NASDAQ:SNY) by 307.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 167,096 shares of the company’s stock after purchasing an additional 126,048 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Sanofi were worth $8,097,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the business. Raymond James Financial Inc. lifted its stake in Sanofi by 81.3% in the 2nd quarter. Raymond James Financial Inc. now owns 5,879,894 shares of the company’s stock worth $284,058,000 after acquiring an additional 2,635,867 shares in the last quarter. Mondrian Investment Partners LTD purchased a new stake in Sanofi in the 3rd quarter worth about $171,742,000. Natixis Advisors LLC lifted its stake in Sanofi by 11.8% in the 3rd quarter. Natixis Advisors LLC now owns 3,113,381 shares of the company’s stock worth $146,952,000 after acquiring an additional 327,569 shares in the last quarter. Equity Investment Corp lifted its stake in Sanofi by 3.0% in the 3rd quarter. Equity Investment Corp now owns 2,587,690 shares of the company’s stock worth $122,139,000 after acquiring an additional 75,255 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in Sanofi by 19.4% in the 3rd quarter. American Century Companies Inc. now owns 2,338,969 shares of the company’s stock worth $110,399,000 after acquiring an additional 379,784 shares in the last quarter. 14.03% of the stock is owned by hedge funds and other institutional investors.

Sanofi Stock Down 1.4%

Shares of SNY stock opened at $44.29 on Friday. The stock’s 50 day simple moving average is $45.58 and its 200 day simple moving average is $47.23. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01. Sanofi has a twelve month low of $42.33 and a twelve month high of $53.03. The company has a market capitalization of $108.02 billion, a price-to-earnings ratio of 12.37, a PEG ratio of 1.11 and a beta of 0.35.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Wednesday, June 3rd. Investors of record on Monday, May 4th will be paid a $2.4225 dividend. This represents a dividend yield of 559.0%. The ex-dividend date of this dividend is Monday, May 4th. This is a positive change from Sanofi’s previous annual dividend of $2.04. Sanofi’s dividend payout ratio (DPR) is 49.16%.

Analyst Upgrades and Downgrades

SNY has been the subject of several research analyst reports. Citigroup reissued a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. BNP Paribas Exane downgraded Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price target for the company. in a research note on Monday, April 20th. Weiss Ratings raised Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Argus raised Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. Finally, Bank of America downgraded Sanofi from a “buy” rating to a “neutral” rating in a research note on Thursday, February 12th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $51.00.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.